Cerebrospinal fluid interleukin 6 in amyotrophic lateral sclerosis: immunological parameter and comparison with inflammatory and non-inflammatory central nervous system diseases.
about
Expression and localization of cyclooxygenase-1 and -2 in human sporadic amyotrophic lateral sclerosisMechanisms of neurodegeneration in amyotrophic lateral sclerosisLate onset of motor neurons in mice overexpressing wild-type peripherinChemokine MIP-2/CXCL2, acting on CXCR2, induces motor neuron death in primary culturesThe role of oxidative stress in degeneration of the neuromuscular junction in amyotrophic lateral sclerosisInflammation in ALS and SMA: sorting out the good from the evil.Evaluating the levels of interleukin-1 family cytokines in sporadic amyotrophic lateral sclerosis.Cross-talk between IGF-1 and estrogen receptors attenuates intracellular changes in ventral spinal cord 4.1 motoneuron cells because of interferon-gamma exposure.NP001 regulation of macrophage activation markers in ALS: a phase I clinical and biomarker studyTumor necrosis factor-alpha, interleukin-1beta, and interleukin-6 in the cerebrospinal fluid of patients with cervical myelopathy and lumbar radiculopathyA comparison of in vitro properties of resting SOD1 transgenic microglia reveals evidence of reduced neuroprotective functionCirculating endotoxin and systemic immune activation in sporadic amyotrophic lateral sclerosis (sALS).Activation of interferon signaling pathways in spinal cord astrocytes from an ALS mouse model.Therapeutic potential of mesenchymal stromal cells and MSC conditioned medium in Amyotrophic Lateral Sclerosis (ALS)--in vitro evidence from primary motor neuron cultures, NSC-34 cells, astrocytes and microglia.Early-stage treatment with Withaferin A reduces levels of misfolded superoxide dismutase 1 and extends lifespan in a mouse model of amyotrophic lateral sclerosis.Molecular and cellular pathways of neurodegeneration in motor neurone diseaseAlsin and SOD1(G93A) proteins regulate endosomal reactive oxygen species production by glial cells and proinflammatory pathways responsible for neurotoxicityHumoral factors in ALS patients during disease progression.A Multiplex Protein Panel Applied to Cerebrospinal Fluid Reveals Three New Biomarker Candidates in ALS but None in Neuropathic Pain Patients.Complex Inflammation mRNA-Related Response in ALS Is Region DependentAmyotrophic lateral sclerosis: contemporary concepts in etiopathogenesis and pharmacotherapy.Interleukin-6 Deficiency Does Not Affect Motor Neuron Disease Caused by Superoxide Dismutase 1 Mutation.Gene expression profiling in peripheral blood mononuclear cells from patients with sporadic amyotrophic lateral sclerosis (sALS)Biomarkers for amyotrophic lateral sclerosis.Neurotrophic factors and amyotrophic lateral sclerosis.Plasma and cerebrospinal fluid-based protein biomarkers for motor neuron disease.Intraperitoneally administered IgG from patients with amyotrophic lateral sclerosis or from an immune-mediated goat model increase the levels of TNF-α, IL-6, and IL-10 in the spinal cord and serum of mice.T cells in amyotrophic lateral sclerosis.Protein biomarkers for amyotrophic lateral sclerosis.Therapy development for ALS: lessons learned and path forward.Efficacy of thalidomide for the treatment of amyotrophic lateral sclerosis: a phase II open label clinical trialThe executioners sing a new song: killer caspases activate microglia.CSF markers in amyotrophic lateral sclerosis.Proteome analysis of body fluids for amyotrophic lateral sclerosis biomarker discovery.Glycoprotein NMB: an Emerging Role in Neurodegenerative Disease.Further development of biomarkers in amyotrophic lateral sclerosis.Characterization of the kynurenine pathway in NSC-34 cell line: implications for amyotrophic lateral sclerosis.Intrathecal upregulation of granulocyte colony stimulating factor and its neuroprotective actions on motor neurons in amyotrophic lateral sclerosis.Cortisol is increased in postmortem cerebrospinal fluid of multiple sclerosis patients: relationship with cytokines and sepsis.A neuroprotective astrocyte state is induced by neuronal signal EphB1 but fails in ALS models.
P2860
Q24295307-FFEF28C3-3566-4380-A64D-DBA1BE99236FQ28365454-BB0346B3-6D29-404D-BF3C-5FD4B1308BFEQ28513274-D16FDDA3-828A-435C-8705-4907CBCD8DC4Q28581270-C4B3EBA3-35DB-40CD-8DE8-3A69B0C9AE54Q33633778-19B2B4D5-1AAB-4594-A1E5-E0763D5DECE9Q33664711-EBB201D8-8252-447E-A02E-1EF5F0362C18Q33689422-4794D9E0-3510-41D5-81D0-11A3597F2F7BQ33869940-4777BCA0-9FFD-45D3-8B1C-88FC1D3D8358Q33924917-0B3E83C0-09C0-4C8F-8C28-BC6C8ECC2378Q33972343-623C28CD-3262-4C9D-BCF1-631BE33F09A6Q34029114-6327CAE4-A961-4B6F-8027-F2A1E91DEAFBQ34369439-42B98ADD-FC7D-4D19-90FF-FCEF5EC130B1Q34798823-E90FFD98-8DD6-4670-9E13-998848AE1B5AQ34998538-6CA307BF-32A5-42F9-A434-D5B18FDA96B3Q35064952-AC048EFD-6753-4DB0-8E55-86A27BB1562FQ35489359-E913FEC6-3D96-4744-B131-DF6E15485C5DQ35562672-B189E2C3-0956-4B57-9F47-B88605CBC5F3Q35806256-41B80D77-197F-4C0A-8733-FBA7FB43FE53Q35935713-D9322E16-000B-46E6-8DC1-C164D5EEBF25Q35957868-88CF7464-ABCC-4619-A745-9805FD535224Q35964723-0C4B2D7E-5821-4105-9DB1-ADABA01D1A84Q35986943-A9830563-A0A7-476D-889B-9E500B0925F2Q36251872-B08A1E49-04D3-4C93-8AF9-34A0A8431B83Q36481118-BE81521F-1293-4D2A-B59F-F2DA584B02C0Q36565607-49D4DE62-6CD5-472C-8DB0-2D572F2FB4F6Q36615226-E10EB39D-0AC1-430C-9537-79E72741D179Q36934383-6AD3D4F9-56DC-4681-9932-14589C3A75E6Q37081721-F6ADF84C-EEE2-4939-BEEE-F2AD7C54D014Q37157841-961227FE-677F-443B-AA45-C2E599277913Q37198692-0BF3A594-31F8-4C4E-A085-D6B5B10B2E56Q37288200-B7EBCD7A-797B-418A-93DB-4EE970F9CFD6Q37916221-343B0DCB-075F-4E13-AA82-987306945CFCQ38007362-25DCECCB-C5F1-45A5-8B1D-EB05DAE32CA3Q38058054-521082E1-7F91-4723-9EA2-2AF232EA15EAQ38693732-483EE5D3-9069-4C2B-976C-8730439A983BQ38856405-D42D7738-BCE0-4FE9-B335-000D06425147Q39616472-EE4BA338-BC33-4211-8F54-48F7FEDA7ACCQ40245798-517B35D4-BA92-4F5B-BA64-612910612023Q42523779-0B9F10A3-45A9-4D42-AE23-C6B92FCD690EQ42611700-F26888DE-5167-496C-B9AC-D471EECAB266
P2860
Cerebrospinal fluid interleukin 6 in amyotrophic lateral sclerosis: immunological parameter and comparison with inflammatory and non-inflammatory central nervous system diseases.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Cerebrospinal fluid interleuki ...... ntral nervous system diseases.
@en
Cerebrospinal fluid interleuki ...... ntral nervous system diseases.
@nl
type
label
Cerebrospinal fluid interleuki ...... ntral nervous system diseases.
@en
Cerebrospinal fluid interleuki ...... ntral nervous system diseases.
@nl
prefLabel
Cerebrospinal fluid interleuki ...... ntral nervous system diseases.
@en
Cerebrospinal fluid interleuki ...... ntral nervous system diseases.
@nl
P2093
P921
P1476
Cerebrospinal fluid interleuki ...... ntral nervous system diseases.
@en
P2093
P304
P356
10.1016/S0022-510X(97)00228-1
P577
1998-02-01T00:00:00Z